High Outlier
Strength
15 mg/.4mL
Manufacturer
Antares Pharma, Inc.NDC
54436001504
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
4/1/2025
Active Ingredients
METHOTREXATEApproval Type
New Drug (NDA)
FDA Application
NDA204824On Market Since
10/11/2013
Pharmacological Classes
Folate Analog Metabolic Inhibitor
Folic Acid Metabolism Inhibitors
Related Drugs
Same classification